ORAL RITLECITINIB AND BREPOCITINIB IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS: DATA FROM THE VIBRATO UMBRELLA STUDY

William Sandborn  ¹     Silvio Danese  ²     Jaroslaw Leszczyszyn  ³     Jacek Romatowski  ⁴     Engin Altintas  ⁵     Elena Peeva  ⁶     Michael Vincent  ⁶     Padmalatha Reddy  ⁶     Christopher Banfield  ⁶     Anindita Banerjee  ⁶     Jeremy Gale  ⁶     Kenneth Hung  ^6    
1 University of California San Diego, La Jolla, United States
² Humanitas Research Hospital, Milan, Italy
³ Melita Medical, Wroclaw, Poland
⁴ Provincial Complex Hospital, Bialystok, Poland
⁵ Mersin University, Mersin, Turkey
⁶ Pfizer Inc, Cambridge, United States

Topic
IBD

Session
IBD: Clinical trials II (small molecules)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)